Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, April 27 2015 6:39am ET - U.S. Markets open in 2 hours and 51 minutes.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Biotechnology News
Latest News
Monday, Apr 27, 2015
·OncoGenex Regains Rights to Custirsen from Teva
PR Newswire - 9 minutes ago
·OncoGenex Regains Rights to Custirsen from Teva
CNW Group - 9 minutes ago
·Sweden's Sobi confirms in preliminary talks on bid for company
Reuters - Mon 3:07 am ET
·Evogene CEO Ofer Haviv and Marrone Bio Innovations CEO Pam Marrone to Participate in 'Profiling Tomorrow's Ag Solutions' Panel Discussion at AgriVest 2015
GlobeNewswire - Mon 2:00 am ET
Sunday, Apr 26, 2015
·Gene Therapy Stocks on Watch Following Failure of Celladon's Heart Failure Trial
at - Sun 8:45 pm ET
·Pharmaceutical company Sobi said to be open to sale -Bloomberg
Reuters - Sun 8:25 pm ET
·Celladon Reports Negative Results for CUPID2 Trial of MYDICAR(R) in Advanced Heart Failure
GlobeNewswire - Sun 4:40 pm ET
Saturday, Apr 25, 2015
·Late-Breaking Oral Presentation at The International Liver Congress™ (ILC 2015) Highlights RG-101's Potent, Durable and Pan-Genotypic Effects in Diverse HCV Population
PR Newswire - Sat 11:45 am ET
·Enanta Pharmaceuticals Announces Preliminary Data from AbbVie’s Phase 3b RUBY-I Study in Chronic Hepatitis C Patients with Renal Impairment Presented at The International Liver Congress™ 2015
Business Wire - Sat 10:04 am ET
·AbbVie Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX® + EXVIERA® in Chronic Hepatitis C Patients with Renal Impairment at The International Liver Congress™ 2015
PR Newswire - Sat 10:00 am ET
·Achillion Presents Detailed Clinical Results on ACH-3102 and ACH-3422 at the International Liver Congress
GlobeNewswire - Sat 9:30 am ET
·Gilead Announces Results From Studies Evaluating Sofosbuvir-Based Regimens in Chronic Hepatitis C Patients With Genotypes 2-5
Business Wire - Sat Apr 25
Friday, Apr 24, 2015
·Final Glance: Biotechnology companies
AP - Fri Apr 24
·New Data Shows Greater In Vitro Potency for VIBATIV(R) (Telavancin) Against Multidrug-Resistant Gram-Positive Bacteria, Including MRSA, Compared to Alternative Antibiotic Treatments
Marketwire - Fri Apr 24
·Vertex Earnings Preview: What You Should Know
at Investopedia - Fri Apr 24
·Celgene Earnings Preview: What You Need to Know
at Investopedia - Fri Apr 24
·SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline -- ACAD
GlobeNewswire - Fri Apr 24
·Biogen's MS Drug Sales Light, Alzheimer's Data Pushed Back
Investor's Business Daily, Inc. - Fri Apr 24
·Notice of Summons and Complaint Against Defendants Milla Bjorn a/k/a Kamilla Bjorlin and Lidingo LLC in the Shareholder Class Action Against Galena Biopharma, Inc. -- GALE
GlobeNewswire - Fri Apr 24
·IGI Laboratories To Hold Conference Call For 1st Quarter 2015 Results
PR Newswire - Fri Apr 24
More Latest News...
Sponsor Results
MUSA Services
BioTech/ Pharma/ MedDev /Healthcare GMP, GCP, GLP, Validation, HIPAA
#1 Stock Secret For 2015
Incredible Annual Gain of 26% Since 1988. Claim Your Free Report.
Top Laboratory Equipment
World-Class Customer Service. Get the Right Lab Equipment Today.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Biotechnology Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?